About us Contact Terms of Use Data Sources Publications FAQ
GSTM3 logo

GSTM3

Glutathione S-transferase Mu 3

Expression

StudyTumor samplesMaxQ3Q2Q1MinNormal samplesMaxQ3Q2Q1MinLog2 (T vs N)
Adrenocortical (ACC) 77 2.35 1.96 1.75 1.45 0.45 126 2.32 1.97 1.78 1.62 -0.09 -0.04
Bladder (BLCA) 406 3.24 2.20 1.73 1.40 0.46 9 2.52 2.31 2.11 1.80 1.73 -0.38
Breast (BRCA) 1067 3.12 2.26 2.00 1.66 0.45 178 2.83 2.05 1.85 1.72 1.32 0.15
Cervical (CESC) 297 3.12 1.89 1.63 1.37 0.50 10 2.18 2.15 1.98 1.85 1.23 -0.34
Cholangiocarcinoma (CHOL) 36 2.26 1.84 1.60 1.42 0.58 0
Colon (COAD) 443 2.35 1.68 1.43 1.13 0.31 166 2.25 1.95 1.72 1.52 -0.09 -0.28
B-cell lymphoma (DLBC) 42 1.66 1.23 1.10 0.97 0.42 337 1.91 1.15 0.94 0.73 -0.04 0.15
Esophageal (ESCA) 142 2.91 1.92 1.61 1.34 0.24 271 2.48 2.03 1.81 1.63 -0.09 -0.20
Glioblastoma (GBM) 160 2.63 2.09 1.93 1.80 1.47 214 2.43 1.91 1.83 1.74 -0.09 0.09
Head and neck (HNSC) 432 3.00 1.93 1.56 1.26 0.29 55 2.35 1.77 1.59 1.40 1.05 -0.03